Torrent Pharmaceuticals Profit & Loss Annual

Trade
BSE: 500420 | NSE: TORNTPHARM | ISIN: INE685A01028 | Sector: Biotechnology & Drugs
3,258.50 +87.95 (2.77%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 10,728.009,620.158,508.048,004.83
Total Revenue 10,728.009,620.158,508.048,004.83
Costof Revenue Total 2,686.002,827.692,537.472,235.30
Gross Profit 8,042.006,792.465,970.575,769.53
Selling/ General/ Admin Expenses Total 1,984.003,447.243,060.612,822.98
Depreciation/ Amortization 808.00702.03661.93657.31
Unusual Expense( Income) -88.004.56484.930.48
Other Operating Expenses Total 2,690.00471.90440.04435.69
Total Operating Expense 8,080.007,484.697,223.636,176.94
Operating Income 2,648.002,135.461,284.411,827.89
Interest Inc( Exp) Net- Non- Op Total -3,540.00-3,160.30-661.00-3,035.40
Other Net 58.006.117.601.91
Net Income Before Taxes 2,352.001,847.161,225.911,526.26
Provisionfor Income Taxes 696.00601.93448.73274.38
Net Income After Taxes 1,656.001,245.23777.181,251.88
Net Income Before Extra Items 1,656.001,245.23777.181,251.88
Net Income 1,656.001,245.23777.181,251.88
Income Availableto Com Excl Extra Ord 1,656.001,245.23777.181,251.88
Income Availableto Com Incl Extra Ord 1,656.001,245.23777.181,251.88
Diluted Net Income 1,656.001,245.23777.181,251.88
Diluted Weighted Average Shares 33.8433.8433.8433.84
Diluted EPS Excluding Extra Ord Items 48.9436.7922.9636.99
DPS- Common Stock Primary Issue 28.0022.0016.5017.50
Diluted Normalized EPS 47.1136.4532.0537.00
Research Development -312.70386.50251.80
Gain( Loss)on Saleof Assets -216.20--
Minority Interest -0.000.000.00
Total Extraordinary Items ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts